CELLCHEM PHARMACEUTICALS INC. - paieškos rezultatas

Europos Sąjunga - portugalų - EMA (European Medicines Agency)

lytgobi

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - agentes antineoplásicos - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Europos Sąjunga - portugalų - EMA (European Medicines Agency)

jaypirca

eli lilly nederland b.v. - pirtobrutinib - linfoma, mantle-cell - inibidores de proteína quinase - treatment of mantle cell lymphoma (mcl).

Europos Sąjunga - portugalų - EMA (European Medicines Agency)

ayvakyt

blueprint medicines (netherlands) b.v. - avapritinib - tumores do estromal gastrointestinal - outros agentes antineoplásicos, inibidores de proteína quinase - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.